Gut Microbiome Metagenomics Analysis Suggests a Functional Model for the Development of Autoimmunity for Type 1 Diabetes
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Recent studies have suggested a bacterial role in the development of autoimmune disorders including type 1 diabetes (T1D). Over 30 billion nucleotide bases of Illumina shotgun metagenomic data were analyzed from stool samples collected from four pairs of matched T1D case-control subjects collected at the time of the development of T1D associated autoimmunity (i.e., autoantibodies). From these, approximately one million open reading frames were predicted and compared to the SEED protein database. Of the 3,849 functions identified in these samples, 144 and 797 were statistically more prevalent in cases and controls, respectively. Genes involved in carbohydrate metabolism, adhesions, motility, phages, prophages, sulfur metabolism, and stress responses were more abundant in cases while genes with roles in DNA and protein metabolism, aerobic respiration, and amino acid synthesis were more common in controls. These data suggest that increased adhesion and flagella synthesis in autoimmune subjects may be involved in triggering a T1D associated autoimmune response. Extensive differences in metabolic potential indicate that autoimmune subjects have a functionally aberrant microbiome. Mining 16S rRNA data from these datasets showed a higher proportion of butyrate-producing and mucin-degrading bacteria in controls compared to cases, while those bacteria that produce short chain fatty acids other than butyrate were higher in cases. Thus, a key rate-limiting step in butyrate synthesis is more abundant in controls. These data suggest that a consortium of lactate- and butyrate-producing bacteria in a healthy gut induce a sufficient amount of mucin synthesis to maintain gut integrity. In contrast, non-butyrate-producing lactate-utilizing bacteria prevent optimal mucin synthesis, as identified in autoimmune subjects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Recent findings linked an aberrant microbiome, which is generally represented by diminished diversity, including fewer butyrate-producing (butyrate was shown to trigger mucin production and hence gut integrity) and mucin-degrading bacteria,241 to the development of autoimmunity in T1DM.242”
From Pancreatic regulation of glucose homeostasis. (2016) · cites this paper as [241]
The cited source says what the claim attributes to it.
In the citing paper
“The authors further indicate that a decrease in Prevotella might be related with a reduction in mucin synthesis which is associated with increased gut permeability (Brown et al., 2011;Forsyth et al., 2011) intensifying the translocation of bacterial antigens.”
From The Gut-Brain Axis in Parkinson’s Disease: Possibilities for Food-Based Therapies (2017) · cites this paper as Brown et al., 2011
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Abnormalities of GI motility might increase the occurrence of SIBO which is highly prevalent in PD patients (Brown et al., 2011;Sánchez-Ferro et al., 2015), even in recently diagnosed PD patients (Tan et al., 2014).”
From The Gut-Brain Axis in Parkinson’s Disease: Possibilities for Food-Based Therapies (2017) · cites this paper as Brown et al., 2011
Experimental — accuracy not yet measuredIn the citing paper
“As mentioned before, SIBO is highly prevalent in PD (Andrews et al., 2009;Brown et al., 2011) and PD patients that tested positive for SIBO are predisposed to worse motordysfunction (Tan et al., 2014).”
From The Gut-Brain Axis in Parkinson’s Disease: Possibilities for Food-Based Therapies (2017) · cites this paper as Brown et al., 2011
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2005) · Statistics for Biology and Health · doi:10.1007/0-387-27255-0_9 · Cited by 20,133
McCullagh, P., & Nelder, J. A. (1989) · doi:10.1007/978-1-4899-3242-6 · Cited by 16,836
Frank, D. N., St. Amand, A. L., Feldman, R. A., Boedeker, E. C., Harpaz, N., & Pace, N. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706625104 · Cited by 4,611 · cited 3×
“At the phylum level and at p-values less than 0.001, Actinobacteria, Bacteroidetes, and Proteobacteria were higher in cases while Firmicutes, Fusobacteria, Tenericutes, and Verrucomicrobia were higher in controls.”
BackgroundInfluentialGeneralized, Linear, and Mixed Models
McCulloch, C. E., & Searle, S. R. (2000) · Wiley Series in Probability and Statistics · doi:10.1002/0471722073 · Cited by 2,994
Review article: the role of butyrate on colonic function
HAMER, H. M., JONKERS, D., VENEMA, K., VANHOUTVIN, S., TROOST, F. J., & BRUMMER, R. ‐. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03562.x · Cited by 2,721 · cited 1×
“Butyrate is known as an anti-inflammatory short chain fatty acid that contributes to colon health [31–33].”
BackgroundThe Effect of Infections on Susceptibility to Autoimmune and Allergic Diseases
Bach, J.-F. (2002) · New England Journal of Medicine · doi:10.1056/nejmra020100 · Cited by 2,687
Louis, P., & Flint, H. J. (2009) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2009.01514.x · Cited by 2,179 · cited 1×
“Butyrate is known as an anti-inflammatory short chain fatty acid that contributes to colon health [31–33].”
BackgroundPeng, L., Li, Z.-R., Green, R. S., Holzmanr, I. R., & Lin, J. (2009) · The Journal of Nutrition · doi:10.3945/jn.109.104638 · Cited by 2,130
Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium
Derrien, M., Vaughan, E. E., Plugge, C. M., & de Vos, W. M. (2004) · International Journal of Systematic and Evolutionary Microbiology · doi:10.1099/ijs.0.02873-0 · Cited by 2,094 · cited 2×
“Perspective signatures of increased mucin synthesis in the gut may be the presence of Prevotella and Akkermansia as both genera are known to degrade mucin [30,39].”
BackgroundInnate immunity and intestinal microbiota in the development of Type 1 diabetes
Wen, L., Ley, R. E., Volchkov, P. Y., Stranges, P. B., Avanesyan, L., Stonebraker, A. C., Hu, C., Wong, F. S., Szot, G. L., Bluestone, J. A., et al. (2008) · Nature · doi:10.1038/nature07336 · Cited by 1,921 · cited 2×
“Intestinal microbes and the innate immune system also interact to affect the development of diabetes in NOD mice [15].”
Background
Cited by
The role of short chain fatty acids in health and disease
Tan, J., McKenzie, C., Potamitis, M., Thorburn, A. N., Mackay, C. R., & Macia, L. (2014) · Advances in immunology · doi:10.1016/b978-0-12-800100-4.00003-9 · Cited by 2,425
Plovier, H., Everard, A., Druart, C., Depommier, C., Van Hul, M., Geurts, L., Chilloux, J., Ottman, N., Duparc, T., Lichtenstein, L., et al. (2017) · Nature Medicine · doi:10.1038/nm.4236 · Cited by 2,204
Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity
Markle, J. G. M., Frank, D. N., Mortin-Toth, S., Robertson, C. E., Feazel, L. M., Rolle-Kampczyk, U., von Bergen, M., McCoy, K. D., Macpherson, A. J., & Danska, J. S. (2013) · Science · doi:10.1126/science.1233521 · Cited by 2,025
Temporal development of the gut microbiome in early childhood from the TEDDY study
Stewart, C. J., Ajami, N. J., O’Brien, J. L., Hutchinson, D. S., Smith, D. P., Wong, M. C., Ross, M. C., Lloyd, R. E., Doddapaneni, H., Metcalf, G. A., et al. (2018) · Nature · doi:10.1038/s41586-018-0617-x · Cited by 2,014
Self-citationGut microbiota are related to Parkinson's disease and clinical phenotype
Scheperjans, F., Aho, V., Pereira, P. A. B., Koskinen, K., Paulin, L., Pekkonen, E., Haapaniemi, E., Kaakkola, S., Eerola‐Rautio, J., Pohja, M., et al. (2015) · Movement Disorders · doi:10.1002/mds.26069 · Cited by 1,968
“Decreased Prevotellaceae abundance also fits well with observations of increased gut permeability in PD because low Prevotella levels may indicate decreased mucin synthesis, which is associated with increased gut permeability.(53,71) Increased mucosal permeability could lead to local and systemic exposure to bacterial…”
BackgroundParker, B. J., Wearsch, P. A., Veloo, A. C. M., & Rodriguez-Palacios, A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00906 · Cited by 1,701
“Alistipes was shown to increase in abundance in the mice cohort receiving the probiotic (45, 60).”
BackgroundOdamaki, T., Kato, K., Sugahara, H., Hashikura, N., Takahashi, S., Xiao, J.-Z., Abe, F., & Osawa, R. (2016) · BMC Microbiology · doi:10.1186/s12866-016-0708-5 · Cited by 1,521
“In addition, a low gut microbiota diversity has been associated with an increasing number of conditions, such as autism [38], autoimmune disease [39] and obesity [40].”
BackgroundBBMerge – Accurate paired shotgun read merging via overlap
Bushnell, B., Rood, J., & Singer, E. (2017) · PLOS ONE · doi:10.1371/journal.pone.0185056 · Cited by 1,544
Kostic, A. D., Gevers, D., Siljander, H., Vatanen, T., Hyötyläinen, T., Hämäläinen, A.-M., Peet, A., Tillmann, V., Pöhö, P., Mattila, I., et al. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.01.001 · Cited by 1,186
“Prospective studies are required to assess whether the microbiota is similarly involved in human T1D progression; however, such cohorts are exceedingly difficult to build (Brown et al., 2011; Giongo et al., 2011).”
Self-citationImpacts of gut bacteria on human health and diseases
Zhang, Y.-J., Li, S., Gan, R.-Y., Zhou, T., Xu, D.-P., & Li, H.-B. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16047493 · Cited by 1,055
“T1D cases compared to controls [86].”
Pancreatic regulation of glucose homeostasis.
Röder, P. V., Wu, B., Liu, Y., & Han, W. (2016) · Experimental & Molecular Medicine · doi:10.1038/emm.2016.6 · Cited by 985
Murri, M., Leiva, I., Gomez-Zumaquero, J. M., Tinahones, F. J., Cardona, F., Soriguer, F., & Queipo-Ortuño, M. I. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-46 · Cited by 765
“Only a few studies have evaluated the ecology of intestinal microbiota in autoimmune children who were not yet diabetic [21,22].”
BackgroundInfluentialHuman gut microbiota in health and disease: Unveiling the relationship
Afzaal, M., Saeed, F., Shah, Y. A., Hussain, M., Rabail, R., Socol, C. T., Hassoun, A., Pateiro, M., Lorenzo, J. M., Rusu, A. V., et al. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.999001 · Cited by 762
“In contrast, mucin synthesis was inhibited by non-butyrate producing lactateutilizing bacteria contributing to autoimmunity of β-cells and type 1 diabetes (Brown et al., 2011).”
BackgroundRole of intestinal microbiota and metabolites on gut homeostasis and human diseases
Lin, L., & Zhang, J. (2017) · BMC Immunology · doi:10.1186/s12865-016-0187-3 · Cited by 731
Environmental risk factors for type 1 diabetes
Rewers, M., & Ludvigsson, J. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30507-4 · Cited by 676
Probiotics modulated gut microbiota suppresses hepatocellular carcinoma growth in mice
Li, J., Sung, C. Y. J., Lee, N., Ni, Y., Pihlajamäki, J., Panagiotou, G., & El-Nezami, H. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1518189113 · Cited by 626
“The relative abundance of Alistipes, a major SCFAs producer in gut (25), decreased in the control group but increased in the ProPre and ProTreat groups by 32% and 29%, respectively.”
BackgroundMicrobial endocrinology: the interplay between the microbiota and the endocrine system
Neuman, H., Debelius, J. W., Knight, R., & Koren, O. (2015) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuu010 · Cited by 613
“4 (Brown et al., 2011; Hara et al., 2013).”
Fecal Microbiota Composition Differs Between Children With β-Cell Autoimmunity and Those Without
de Goffau, M. C., Luopajärvi, K., Knip, M., Ilonen, J., Ruohtula, T., Härkönen, T., Orivuori, L., Hakala, S., Welling, G. W., Harmsen, H. J., et al. (2013) · Diabetes · doi:10.2337/db12-0526 · Cited by 557
“A role of the Bacteroides genus in the development of autoimmune diabetes has been implicated in animal models and in humans (11,12,14,33).”
BackgroundResultSelf-citationGut microbiota, obesity and diabetes
Patterson, E., Ryan, P. M., Cryan, J. F., Dinan, T. G., Ross, R. P., Fitzgerald, G. F., & Stanton, C. (2016) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2015-133285 · Cited by 552
Intestinal Barrier in Human Health and Disease
Di Tommaso, N., Gasbarrini, A., & Ponziani, F. R. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph182312836 · Cited by 533
“PPIs can also modulate the intestinal barrier, interfering with smooth muscle relaxation, phosphatase activity, and local electrolyte homeostasis (i.e., Ca and K), and hence, with the function of TJs [77–79].”
BackgroundInfluentialLazar, V., Ditu, L.-M., Pircalabioru, G. G., Gheorghe, I., Curutiu, C., Holban, A. M., Picu, A., Petcu, L., & Chifiriuc, M. C. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01830 · Cited by 525
“T1DM is associated with a low diversity of microbiota and with the expansion of distinct groups of bacteria (93, 94).”
BackgroundCaptivity humanizes the primate microbiome
Clayton, J. B., Vangay, P., Huang, H., Ward, T., Hillmann, B. M., Al-Ghalith, G. A., Travis, D. A., Long, H. T., Tuan, B. V., Minh, V. V., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1521835113 · Cited by 508
The hygiene hypothesis in autoimmunity: the role of pathogens and commensals
Bach, J.-F. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.111 · Cited by 515
Queipo-Ortuño, M. I., Seoane, L. M., Murri, M., Pardo, M., Gomez-Zumaquero, J. M., Cardona, F., Casanueva, F., & Tinahones, F. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065465 · Cited by 497
“and Lactobacillus have the capacity to produce the organic acid lactate, which is converted into butyrate by butyrate-producing bacteria in the gut [46].”
The heterogeneous pathogenesis of type 1 diabetes mellitus
Ilonen, J., Lempainen, J., & Veijola, R. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0254-y · Cited by 494
Self-citationSleep, circadian rhythm, and gut microbiota
Matenchuk, B. A., Mandhane, P. J., & Kozyrskyj, A. L. (2020) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2020.101340 · Cited by 495
The role of Gut Microbiota in the development of obesity and Diabetes
Baothman, O. A., Zamzami, M. A., Taher, I., Abubaker, J., & Abu-Farha, M. (2016) · Lipids in Health and Disease · doi:10.1186/s12944-016-0278-4 · Cited by 493
Hildebrand, F., Nguyen, T. L. A., Brinkman, B., Yunta, R. G., Cauwe, B., Vandenabeele, P., Liston, A., & Raes, J. (2013) · Genome Biology · doi:10.1186/gb-2013-14-1-r4 · Cited by 465
“Dysbiosis of the gut microbiota is linked to many chronic disorders [1], such as inflammatory bowel disease [2-4], obesity [5-7], rheumatoid arthritis [8], autoimmune encephalomyelitis [9,10], type 1 [11,12] and type 2 diabetes [13], and allergic diseases [14].”
Assessing the Human Gut Microbiota in Metabolic Diseases
Karlsson, F., Tremaroli, V., Nielsen, J., & Bäckhed, F. (2013) · Diabetes · doi:10.2337/db13-0844 · Cited by 452
Role of the intestinal microbiome in health and disease: from correlation to causation
de Vos, W. M., & de Vos, E. A. (2012) · Nutrition Reviews · doi:10.1111/j.1753-4887.2012.00505.x · Cited by 440
The role of the intestinal microbiota in type 1 diabetes mellitus
Knip, M., & Siljander, H. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.218 · Cited by 434
Self-citationGut microbiota in multiple sclerosis: possible influence of immunomodulators
Cantarel, B. L., Waubant, E., Chehoud, C., Kuczynski, J., DeSantis, T. Z., Warrington, J., Venkatesan, A., Fraser, C. M., & Mowry, E. M. (2015) · Journal of Investigative Medicine · doi:10.1097/jim.0000000000000192 · Cited by 409
“Patients with type 1 diabetes have been shown to have reduced butyrateproducing and mucin-degrading bacteria compared with controls such that if confirmed, the results herein may imply similarities in the mechanisms by which gut bacteria influence the development of autoimmune disease.(19) On the other hand, wewere un…”
ResultGomez-Arango, L. F., Barrett, H. L., Wilkinson, S. A., Callaway, L. K., McIntyre, H. D., Morrison, M., & Dekker Nitert, M. (2018) · Gut Microbes · doi:10.1080/19490976.2017.1406584 · Cited by 402
“Non-butyrate-producing lactate-utilizing bacteria inhibit intestinal mucin synthesis, which has been associated with pancreatic b cell autoimmunity and type 1 diabetes.(28) Moreover, Collinsella contributes to the pathogenesis in rheumatoid arthritis by increasing gut permeability, reducing the expression of tight jun…”
BackgroundBreast cancer in postmenopausal women is associated with an altered gut metagenome
Zhu, J., Liao, M., Yao, Z., Liang, W., Li, Q., Liu, J., Yang, H., Ji, Y., Wei, W., Tan, A., et al. (2018) · Microbiome · doi:10.1186/s40168-018-0515-3 · Cited by 377
The impact of the gut microbiome on extra-intestinal autoimmune diseases
Miyauchi, E., Shimokawa, C., Steimle, A., Desai, M. S., & Ohno, H. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-022-00727-y · Cited by 367
Gut microbiota, probiotics and diabetes
Gomes, A. C., Bueno, A. A., de Souza, R. G. M., & Mota, J. F. (2014) · Nutrition Journal · doi:10.1186/1475-2891-13-60 · Cited by 363
“In another study, the gut microbiota composition of T1D children showed increased virulence factors, phage, prophage, motility genes and higher response to stress [74].”
Hänninen, A., Toivonen, R., Pöysti, S., Belzer, C., Plovier, H., Ouwerkerk, J. P., Emani, R., Cani, P. D., & De Vos, W. M. (2018) · Gut · doi:10.1136/gutjnl-2017-314508 · Cited by 359
Antibiotic-mediated gut microbiome perturbation accelerates development of type 1 diabetes in mice
Livanos, A. E., Greiner, T. U., Vangay, P., Pathmasiri, W., Stewart, D., McRitchie, S., Li, H., Chung, J., Sohn, J., Kim, S., et al. (2016) · Nature Microbiology · doi:10.1038/nmicrobiol.2016.140 · Cited by 354
Towards microbial fermentation metabolites as markers for health benefits of prebiotics
Verbeke, K. A., Boobis, A. R., Chiodini, A., Edwards, C. A., Franck, A., Kleerebezem, M., Nauta, A., Raes, J., van Tol, E. A. F., & Tuohy, K. M. (2015) · Nutrition Research Reviews · doi:10.1017/s0954422415000037 · Cited by 343
Connecting the immune system, systemic chronic inflammation and the gut microbiome: the role of sex
Rizzetto, L., Fava, F., Tuohy, K. M., & Selmi, C. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.05.008 · Cited by 331
Aberrant gut microbiota composition at the onset of type 1 diabetes in young children
de Goffau, M. C., Fuentes, S., van den Bogert, B., Honkanen, H., de Vos, W. M., Welling, G. W., Hyöty, H., & Harmsen, H. J. M. (2014) · Diabetologia · doi:10.1007/s00125-014-3274-0 · Cited by 326
“In the study by Brown et al, it was shown that the butyrate-producing genera Faecalibacterium (a member of Clostridium cluster IV) and Roseburia (a member of Clostridium cluster XIVa) were more predominant in healthy controls [15].”
BackgroundResultInfluentialSelf-citationCommunity-wide transcriptome of the oral microbiome in subjects with and without periodontitis
Duran-Pinedo, A. E., Chen, T., Teles, R., Starr, J. R., Wang, X., Krishnan, K., & Frias-Lopez, J. (2014) · The ISME Journal · doi:10.1038/ismej.2014.23 · Cited by 327
“Counts were normalized by dividing by the total number of reads for each sample and log-transforming the resulting fractions (Ramette, 2007; Brown et al., 2011).”
MethodThe Human Gut Microbiome and Body Metabolism: Implications for Obesity and Diabetes
Devaraj, S., Hemarajata, P., & Versalovic, J. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2012.187617 · Cited by 321
Intestinal dysbiosis and probiotic applications in autoimmune diseases
de Oliveira, G. L. V., Leite, A. Z., Higuchi, B. S., Gonzaga, M. I., & Mariano, V. S. (2017) · Immunology · doi:10.1111/imm.12765 · Cited by 322
de Groot, P., Nikolic, T., Pellegrini, S., Sordi, V., Imangaliyev, S., Rampanelli, E., Hanssen, N., Attaye, I., Bakker, G., Duinkerken, G., et al. (2021) · Gut · doi:10.1136/gutjnl-2020-322630 · Cited by 316
Integrated multi-omics of the human gut microbiome in a case study of familial type 1 diabetes
Heintz-Buschart, A., May, P., Laczny, C. C., Lebrun, L. A., Bellora, C., Krishna, A., Wampach, L., Schneider, J. G., Hogan, A., de Beaufort, C., et al. (2016) · Nature Microbiology · doi:10.1038/nmicrobiol.2016.180 · Cited by 316
Davis-Richardson, A. G., Ardissone, A. N., Dias, R., Simell, V., Leonard, M. T., Kemppainen, K. M., Drew, J. C., Schatz, D., Atkinson, M. A., Kolaczkowski, B., et al. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00678 · Cited by 308
“…Turku, Finland 7 Department of Pediatrics, Children’s Hospital, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland 8 Diabetes and Obesity Research Program, University of Helsinki, Helsinki, Finland 9 Department of Pediatrics, Tampere University Hospital,…”
BackgroundInfluentialSelf-citationMicrobiota in pancreatic health and disease: the next frontier in microbiome research
Thomas, R. M., & Jobin, C. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0242-7 · Cited by 308
Frequent Replenishment Sustains the Beneficial Microbiome of Drosophila melanogaster
Blum, J. E., Fischer, C. N., Miles, J., & Handelsman, J. (2013) · mBio · doi:10.1128/mbio.00860-13 · Cited by 311
Xu, Q., Ni, J.-J., Han, B.-X., Yan, S.-S., Wei, X.-T., Feng, G.-J., Zhang, H., Zhang, L., Li, B., & Pei, Y.-F. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.746998 · Cited by 295
“Two case-control studies showed that the relative abundance of Bifidobacterium was higher in T1D patients than that in controls (30, 31).”
ResultDing, Y., Yan, Y., Peng, Y., Chen, D., Mi, J., Lu, L., Luo, Q., Li, X., Zeng, X., & Cao, Y. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.12.081 · Cited by 290
Alterations in Intestinal Microbiota Correlate With Susceptibility to Type 1 Diabetes
Alkanani, A. K., Hara, N., Gottlieb, P. A., Ir, D., Robertson, C. E., Wagner, B. D., Frank, D. N., & Zipris, D. (2015) · Diabetes · doi:10.2337/db14-1847 · Cited by 292
“Through similar mechanisms, a Western diet may also be involved in the global rise in the incidence of T1D observed in recent decades (47,53).”
BackgroundIntestinal virome changes precede autoimmunity in type I diabetes-susceptible children
Zhao, G., Vatanen, T., Droit, L., Park, A., Kostic, A. D., Poon, T. W., Vlamakis, H., Siljander, H., Härkönen, T., Hämäläinen, A.-M., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1706359114 · Cited by 286
“Some common observations include increased abundance of the Bacteroides genus (7–9) and reduced abundance of butyrateproducing bacteria (7, 10).”
BackgroundSelf-citationEvaluating Causality of Gut Microbiota in Obesity and Diabetes in Humans
Meijnikman, A. S., Gerdes, V. E., Nieuwdorp, M., & Herrema, H. (2018) · Endocrine Reviews · doi:10.1210/er.2017-00192 · Cited by 278
Gut microbiota influence in type 2 diabetes mellitus (T2DM)
Cunningham, A. L., Stephens, J. W., & Harris, D. A. (2021) · Gut Pathogens · doi:10.1186/s13099-021-00446-0 · Cited by 270
Th17 Cells in Immunity and Autoimmunity
Bedoya, S. K., Lam, B., Lau, K., & Larkin, J. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/986789 · Cited by 282
“A gut microbiomemetagenomics analysis indicated that autoimmune subjects have a functioning aberrant microbiome [232], and children with β-cell autoimmunity, indicative of T1D, have a markedly different composition of gut flora species than do healthy controls [233].”
BackgroundInfluence of Vitamin D on Islet Autoimmunity and Beta-Cell Function in Type 1 Diabetes
Infante, M., Ricordi, C., Sanchez, J., Clare-Salzler, M. J., Padilla, N., Fuenmayor, V., Chavez, C., Alvarez, A., Baidal, D., Alejandro, R., et al. (2019) · Nutrients · doi:10.3390/nu11092185 · Cited by 272
“Main candidate triggers include some viruses (especially enteroviruses) [28–30], gut microbiota [31], dietary factors [32], and toxins (e.”
The gut microbiota: A treasure for human health
Li, D., Wang, P., Wang, P., Hu, X., & Chen, F. (2016) · Biotechnology Advances · doi:10.1016/j.biotechadv.2016.08.003 · Cited by 261
“Metagenomic analysis showed that gut microbiome of children with T1D were enriched in functions including stress responses, virulence factors and sulfur metabolism, whereas functions of DNA, RNA and protein metabolism were enriched in healthy children (Brown et al., 2011).”
BackgroundObesity in Type 1 Diabetes: Pathophysiology, Clinical Impact, and Mechanisms
Corbin, K. D., Driscoll, K. A., Pratley, R. E., Smith, S. R., Maahs, D. M., Mayer-Davis, E. J., & Advancing Care for Type 1 Diabetes and Obesity Network (ACT1ON) (2018) · Endocrine Reviews · doi:10.1210/er.2017-00191 · Cited by 262
McCafferty, J., Mühlbauer, M., Gharaibeh, R. Z., Arthur, J. C., Perez-Chanona, E., Sha, W., Jobin, C., & Fodor, A. A. (2013) · The ISME Journal · doi:10.1038/ismej.2013.106 · Cited by 259
“Mixed linear models have many advantages including a solid theoretical base (Raudenbush and Bryk, 2002; Smyth, 2004), wide utilization in the literature (Brown et al., 2011; Listgarten et al.; Ross et al., 2012; Vilhjalmsson and Nordborg, 2013) and robust implementations in statistical packages such as R and SAS.”
BackgroundThe role of gut microbiota in the development of type 1, type 2 diabetes mellitus and obesity
Tai, N., Wong, F. S., & Wen, L. (2015) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-015-9309-0 · Cited by 252
“The results of the DIPP study suggested that a consortium of lactate- and butyrate-producing bacteria induced mucin synthesis to maintain gut integrity in healthy controls, while non-butyrate-producing lactate-utilizing bacteria prevented mucin synthesis, thus causing β cell autoimmunity and T1D [40].”
MethodHLA-B27 and Human β2-Microglobulin Affect the Gut Microbiota of Transgenic Rats
Lin, P., Bach, M., Asquith, M., Lee, A. Y., Akileswaran, L., Stauffer, P., Davin, S., Pan, Y., Cambronne, E. D., Dorris, M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105684 · Cited by 255
Leiva-Gea, I., Sánchez-Alcoholado, L., Martín-Tejedor, B., Castellano-Castillo, D., Moreno-Indias, I., Urda-Cardona, A., Tinahones, F. J., Fernández-García, J. C., & Queipo-Ortuño, M. I. (2018) · Diabetes Care · doi:10.2337/dc18-0253 · Cited by 253
“propionate-producing bacteria) as the main genus leading to type 1 diabetes– associated dysbiosis (21,22).”
BackgroundGut microbiota of humans, dogs and cats: current knowledge and future opportunities and challenges
Deng, P., & Swanson, K. S. (2015) · British Journal of Nutrition · doi:10.1017/s0007114514002943 · Cited by 249
“In humans, diseases associated with microbial dysbiosis include obesity((8,9)), diabetes((10,11)), inflammatory bowel disease (IBD)((12,13)) and allergies((14)).”
BackgroundTaking it Personally: Personalized Utilization of the Human Microbiome in Health and Disease
Zmora, N., Zeevi, D., Korem, T., Segal, E., & Elinav, E. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2015.12.016 · Cited by 252
“Children with a high risk for developing type 1 diabetes mellitus (T1DM) exhibit dysbiosis and reduced abundance of lactate- and butyrate-producing species even before the overt manifestations of the disease (de Goffau et al., 2013; Kemppainen et al., 2015; Brown et al., 2011).”
BackgroundChen, X., Huang, Y.-A., You, Z.-H., Yan, G.-Y., & Wang, X.-S. (2017) · Bioinformatics · doi:10.1093/bioinformatics/btw715 · Cited by 252
“…the body microbiota is closely associated with a diverse range of human noninfectious diseases such as cancer (Moore and Moore, 1995), diabetes (Brown et al., 2011; Giongo et al., 2011), obesity (Ley et al., 2005; Zhang et al., 2009), kidney stones (Hoppe et al., 2011) and systemic…”
BackgroundGut microbiota, host health, and polysaccharides
Xu, X., Xu, P., Ma, C., Tang, J., & Zhang, X. (2013) · Biotechnology Advances · doi:10.1016/j.biotechadv.2012.12.009 · Cited by 245
“16S rRNA data revealed that a lower proportion of butyrate-producing and mucin-degrading bacteria reside in the intestine of T1D (Brown et al., 2011).”
InfluentialLiu, R. T., Rowan-Nash, A. D., Sheehan, A. E., Walsh, R. F. L., Sanzari, C. M., Korry, B. J., & Belenky, P. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.03.026 · Cited by 242
Fecal microbiota imbalance in Mexican children with type 1 diabetes
Mejía-León, M. E., Petrosino, J. F., Ajami, N. J., Domínguez-Bello, M. G., & de la Barca, A. M. C. (2014) · Scientific Reports · doi:10.1038/srep03814 · Cited by 235
Kim, N., Jeon, S. H., Ju, I. G., Gee, M. S., Do, J., Oh, M. S., & Lee, J. K. (2021) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2021.09.002 · Cited by 231
Impact of gut microbiota on diabetes mellitus
Blandino, G., Inturri, R., Lazzara, F., Di Rosa, M., & Malaguarnera, L. (2016) · Diabetes & Metabolism · doi:10.1016/j.diabet.2016.04.004 · Cited by 231
“n addition, peptidergic enteric neurons, as targets of inflammaion, can modulate immune-cell function and therefore stimulate roinflammatory cytokine production, resulting in neurodegenration [94].”
BackgroundGut microbiome in type 1 diabetes: A comprehensive review
Zheng, P., Li, Z., & Zhou, Z. (2018) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3043 · Cited by 228
“The abundance of short‐chain fatty acids (SCFAs)‐producing bacteria as well as lactate‐producing bacteria was reduced in T1D patients.(50) The reduced number of Lactobacillus and Bifidobacterium could also be observed at the onset of T1D.”
BackgroundResultButyrate enhances mitochondrial function during oxidative stress in cell lines from boys with autism
Rose, S., Bennuri, S. C., Davis, J. E., Wynne, R., Slattery, J. C., Tippett, M., Delhey, L., Melnyk, S., Kahler, S. G., MacFabe, D. F., et al. (2018) · Translational Psychiatry · doi:10.1038/s41398-017-0089-z · Cited by 226
Candon, S., Perez-Arroyo, A., Marquet, C., Valette, F., Foray, A.-P., Pelletier, B., Milani, C., Ventura, M., Bach, J.-F., & Chatenoud, L. (2015) · PLOS ONE · doi:10.1371/journal.pone.0125448 · Cited by 224
“First, in patients, a correlation between the reduction in the diversity of the intestinal microbiota and the occurrence of T1D or anti-islet-cell autoimmunity has been reported [3,5,6,20].”
BackgroundThe immunology of type 1 diabetes
Herold, K. C., Delong, T., Perdigoto, A. L., Biru, N., Brusko, T. M., & Walker, L. S. K. (2024) · Nature Reviews Immunology · doi:10.1038/s41577-023-00985-4 · Cited by 212
“In addition, metabolic products of the microbiome, such as short-chain fatty acids (SCFA), may affect systemic immune regulation, including via direct effects on mucosal-associated invariant T (MAIT) cells 34,37,38,229,230 .”
Loss of gut barrier integrity triggers activation of islet-reactive T cells and autoimmune diabetes
Sorini, C., Cosorich, I., Lo Conte, M., De Giorgi, L., Facciotti, F., Lucianò, R., Rocchi, M., Ferrarese, R., Sanvito, F., Canducci, F., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1814558116 · Cited by 219
Intestinal microbiota in early life and its implications on childhood health
Zhuang, L., Chen, H., Zhang, S., Zhuang, J., Li, Q., & Feng, Z. (2019) · Genomics, Proteomics & Bioinformatics · doi:10.1016/j.gpb.2018.10.002 · Cited by 219
“Compared to healthy controls, DM1 patients harbor a less diverse and less stable intestinal microbiota [95,96], and changes in the proportion of Firmicutes to Bacteroidetes are observed in DM1 patients [95–98].”
BackgroundThe intestinal microbiota: its role in health and disease
Biedermann, L., & Rogler, G. (2015) · European Journal of Pediatrics · doi:10.1007/s00431-014-2476-2 · Cited by 211
“Whereas it might be obvious that bacteria can contribute to intestinal inflammation such as IBD, it seems to be a little bit more surprising that the microbiota also has been associated to metabolic diseases such as diabetes [1, 3, 22, 23, 47, 50, 56, 72, 209], metabolic syndrome [31, 189, 199], or non-alcoholic steat…”
BackgroundThe Human Microbiome: From Symbiosis to Pathogenesis
Eloe-Fadrosh, E. A., & Rasko, D. A. (2013) · Annual Review of Medicine · doi:10.1146/annurev-med-010312-133513 · Cited by 210
Integrative Personal Omics Profiles during Periods of Weight Gain and Loss
Piening, B. D., Zhou, W., Contrepois, K., Röst, H., Gu Urban, G. J., Mishra, T., Hanson, B. M., Bautista, E. J., Leopold, S., Yeh, C. Y., et al. (2018) · Cell Systems · doi:10.1016/j.cels.2017.12.013 · Cited by 212
“Alistipes spp. were shown previously to associate with glucose regulation, diabetes, and obesity (Brown et al., 2011; Ridaura et al., 2013; Serino et al., 2012).”
BackgroundDoes the microbiota play a role in the pathogenesis of autoimmune diseases?
McLean, M. H., Dieguez, D., Miller, L. M., & Young, H. A. (2015) · Gut · doi:10.1136/gutjnl-2014-308514 · Cited by 208
Gut Microbiota, Host Organism, and Diet Trialogue in Diabetes and Obesity
Lazar, V., Ditu, L.-M., Pircalabioru, G. G., Picu, A., Petcu, L., Cucu, N., & Chifiriuc, M. C. (2019) · Frontiers in Nutrition · doi:10.3389/fnut.2019.00021 · Cited by 210
“Patterson et al. employed the streptozocin (STZ)-induced T1DM rat model to gain insights into the diabetes onset and progression in terms of microbiota shifts (70).”
BackgroundInfluentialMicrobial dysbiosis in the gut drives systemic autoimmune diseases
Mousa, W. K., Chehadeh, F., & Husband, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.906258 · Cited by 185
“T1D patients are also deficient in butyrate producers and mucin-degrading bacteria (84).”
BackgroundGut Microbiota and Type 1 Diabetes
Han, H., Li, Y., Fang, J., Liu, G., Yin, J., Li, T., & Yin, Y. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19040995 · Cited by 206
“Butyrate, also one of the SCFAs, maintains the integrity of the gut epithelium by inducing mucin synthesis [66] and improves the intestinal barrier by facilitating tight junction assembly [67], which is involved in autoimmune diseases [68], such as T1D.”
BackgroundEnvironmental Triggers of Type 1 Diabetes
Knip, M., & Simell, O. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a007690 · Cited by 203
“…children revealed that nonbutyrate-producing lactateutilizing bacteria prevented optimal mucin synthesis in the progressors, whereas a consortium of lactate- and butyrate-producing bacteria induced a sufficient amount of mucin synthesis in the controls to maintain gut integrity (Brown et al. 2011).”
BackgroundSelf-citationThe Gut-Brain Axis in Parkinson’s Disease: Possibilities for Food-Based Therapies
Perez-Pardo, P., Kliest, T., Dodiya, H. B., Broersen, L. M., Garssen, J., Keshavarzian, A., & Kraneveld, A. D. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.05.042 · Cited by 203
“The authors further indicate that a decrease in Prevotella might be related with a reduction in mucin synthesis which is associated with increased gut permeability (Brown et al., 2011; Forsyth et al., 2011) intensifying the translocation of bacterial antigens.”
BackgroundGut Microbial Alterations Associated With Protection From Autoimmune Uveitis
Nakamura, Y. K., Metea, C., Karstens, L., Asquith, M., Gruner, H., Moscibrocki, C., Lee, I., Brislawn, C. J., Jansson, J. K., Rosenbaum, J. T., et al. (2016) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.16-19733 · Cited by 193
Review article: the future of microbiome‐based therapeutics
Gulliver, E. L., Young, R. B., Chonwerawong, M., D'Adamo, G. L., Thomason, T., Widdop, J. T., Rutten, E. L., Rossetto Marcelino, V., Bryant, R. V., Costello, S. P., et al. (2022) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.17049 · Cited by 180
Exploring gut microbes in human health and disease: Pushing the envelope
Sun, J., & Chang, E. B. (2014) · Genes & Diseases · doi:10.1016/j.gendis.2014.08.001 · Cited by 194
“In Type I diabetes, “pre-diabetic” subjects can now be identified from whom, stool samples for microbiota analysis are being collected prospectively.(31,32) In IBD, studies of UC patients who undergo total colectomy with Ileal pouch anal anastomosis (IPAA) are being followed prospectively to determine if changes in gu…”
BackgroundZhang, M., Ma, W., Zhang, J., He, Y., & Wang, J. (2018) · Scientific Reports · doi:10.1038/s41598-018-32219-2 · Cited by 188
Huang, B., Chau, S. W. H., Liu, Y., Chan, J. W. Y., Wang, J., Ma, S. L., Zhang, J., Chan, P. K. S., Yeoh, Y. K., Chen, Z., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-38248-4 · Cited by 187
Bioactive compounds for human and planetary health
Kussmann, M., Cunha, D. H. A., & Berciano, S. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1193848 · Cited by 208
“Metagenomic analyses of the human gut microbiome have revealed millions of genes and genomic evidence for its benefits in human health and disease (66).”
BackgroundUnderstanding the role of gut microbiome in metabolic disease risk
Sanz, Y., Olivares, M., Moya-Pérez, Á., & Agostoni, C. (2015) · Pediatric Research · doi:10.1038/pr.2014.170 · Cited by 174
Compromised Gut Microbiota Networks in Children With Anti-Islet Cell Autoimmunity
Endesfelder, D., zu Castell, W., Ardissone, A., Davis-Richardson, A. G., Achenbach, P., Hagen, M., Pflueger, M., Gano, K. A., Fagen, J. R., Drew, J. C., et al. (2014) · Diabetes · doi:10.2337/db13-1676 · Cited by 175
“With this, the role of microbiota in type 1 diabetes pathogenesis has become an important subject of investigation (8-12).”
BackgroundSelf-citationThe Role of the Gut Microbiome in Diabetes and Obesity-Related Kidney Disease
Zaky, A., Glastras, S. J., Wong, M. Y. W., Pollock, C. A., & Saad, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179641 · Cited by 172
“Some studies demonstrated that alterations in the gut microbiota might precede the development of T1D [[69,70,74,80].”
BackgroundCosta, F. R. C., Françozo, M. C. S., de Oliveira, G. G., Ignacio, A., Castoldi, A., Zamboni, D. S., Ramos, S. G., Câmara, N. O., de Zoete, M. R., Palm, N. W., et al. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20150744 · Cited by 176
Alterations of the Human Gut Microbiome in Chronic Kidney Disease
Ren, Z., Fan, Y., Li, A., Shen, Q., Wu, J., Ren, L., Lu, H., Ding, S., Ren, H., Liu, C., et al. (2020) · Advanced Science · doi:10.1002/advs.202001936 · Cited by 177
Parkinson’s Disease and the Gastrointestinal Microbiome
Lubomski, M., Tan, A. H., Lim, S.-Y., Holmes, A. J., Davis, R. L., & Sue, C. M. (2020) · Journal of Neurology · doi:10.1007/s00415-019-09320-1 · Cited by 172
“Furthermore, lowered Prevotella abundance is not entirely specific to PD, as other conditions including type I diabetes [157], colon cancer [158] and autism [159], also share reduced Prevotella abundances.”
BackgroundHarsch, I. A., & Konturek, P. C. (2018) · Medical Sciences · doi:10.3390/medsci6020032 · Cited by 165
“[91] hypothesized that a consortium of lactate- and butyrate-producing bacteria in a healthy gut may induce sufficient mucin synthesis to maintain gut integrity.”
BackgroundThe "Gut Feeling": Breaking Down the Role of Gut Microbiome in Multiple Sclerosis
Freedman, S. N., Shahi, S. K., & Mangalam, A. K. (2018) · Neurotherapeutics · doi:10.1007/s13311-017-0588-x · Cited by 168
“Phytoestrogens are also protective in the nonobese diabetic mouse model of T1D [165] and were associated with shifts in the gut microbiome [166].”
MethodInfluential
Metadata
- Authors
- Brown, C. T., Davis-Richardson, A. G., Giongo, A., Gano, K. A., Crabb, D. B., Mukherjee, N., Casella, G., Drew, J. C., Ilonen, J., Knip, M., Hyöty, H., Veijola, R., Simell, T., Simell, O., Neu, J., Wasserfall, C. H., Schatz, D., Atkinson, M. A., & Triplett, E. W.
- Affiliations
- University of Florida (US)
- University of Eastern Finland (FI)
- University of Helsinki (FI)
- Tampere University Hospital (FI)
- University of Oulu (FI)
- Turku University Hospital (FI)
- Corresponding author
- Triplett, Eric W.
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2011-10-17
- Volume
- 6
- Issue
- 10
- Pages
- e25792
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3197175
- OpenAlex
- W2060915038
- Cited by
- 778
- References
- 48
- Citations by year
- 2026: 17 · 2025: 31 · 2024: 53 · 2023: 60 · 2022: 69 · 2021: 73 · 2020: 66 · 2019: 69 · 2018: 68 · 2017: 59 · 2016: 55 · 2015: 49 · 2014: 47 · 2013: 38 · 2012: 22
- FWCI
- 14.01
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Tampere University Institutional Repository (Tampere University) (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Työväentutkimus Vuosikirja (submittedVersion, other-oa)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Keywords
- type 1 diabetes, gut microbiota, autoimmunity, autoantibodies, metagenomics, bacterial gene function, carbohydrate metabolism, bacterial adhesion, flagella synthesis, butyrate production, short-chain fatty acids, mucin degradation, intestinal barrier integrity, lactate-utilizing bacteria, 16S rRNA
- MeSH terms
- Autoantibodies, Butyrates, Diabetes Mellitus, Type 1, Fatty Acids, Volatile, Humans, Mucins, RNA, Ribosomal, 16S, Autoimmunity, Case-Control Studies, Databases, Nucleic Acid, Gastrointestinal Tract, Metagenome, Metagenomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.